Last Updated:
Name Designation Appointment Date Status
Karan Ahuja

Appointed as Director since November 2021

Director 01-Nov-2021 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Gagneet Singh

Appointed as Director since November 2021

Director 01-Nov-2021 Current
Sanjay Ahuja

Appointed as Director since August 2022

Director 09-Aug-2022 Current

People Timeline

Explore the timeline of key personnel in Jags Pharma Private Limited's leadership journey.

Loading...
Contact Details
  • Address #507 Block B, Elante Office Tower, Plot No. 178-178A, I&B Park, Phase1 Cabin No.-4, Chandigarh Chandigarh, 160002, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 160002
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Jags Pharma Private Limited?
You can contact Jags Pharma Private Limited through their registered address at #507 Block B, Elante Office Tower, Plot No. 178-178A, I&B Park, Phase1 Cabin No.-4, Chandigarh Chandigarh, 160002, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Jags Pharma Private Limited?
The current directors of Jags Pharma Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • Gagneet Singh
  • KARAN AHUJA
  • SANJAY AHUJA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available